View in EDS

Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.

Saved in:
Bibliographic Details
Title: Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.
Authors: Weintraub MJ; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America. Electronic address: mjweintraub@mednet.ucla.edu., Jeffrey JK; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Ichinose MC; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Bergman RL; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Shapiro B; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Barnett G; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Artin H; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Lynn M; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Salimian A; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Grody S; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Ramesh R; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Eales L; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Grob CS; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America; The Lunquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center, United States of America., Miklowitz DJ; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.
Source: Journal of affective disorders [J Affect Disord] 2026 Jun 15; Vol. 403, pp. 121423. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article; Clinical Trial
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41707717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Weintraub+MJ%22">Weintraub MJ</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America. Electronic address: mjweintraub@mednet.ucla.edu.<br /><searchLink fieldCode="AU" term="%22Jeffrey+JK%22">Jeffrey JK</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Ichinose+MC%22">Ichinose MC</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Bergman+RL%22">Bergman RL</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Shapiro+B%22">Shapiro B</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Barnett+G%22">Barnett G</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Artin+H%22">Artin H</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Lynn+M%22">Lynn M</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Salimian+A%22">Salimian A</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Grody+S%22">Grody S</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Ramesh+R%22">Ramesh R</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Eales+L%22">Eales L</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.<br /><searchLink fieldCode="AU" term="%22Grob+CS%22">Grob CS</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America; The Lunquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center, United States of America.<br /><searchLink fieldCode="AU" term="%22Miklowitz+DJ%22">Miklowitz DJ</searchLink>; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227906073%22">Journal of affective disorders</searchLink> [J Affect Disord] 2026 Jun 15; Vol. 403, pp. 121423. <i>Date of Electronic Publication: </i>2026 Feb 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7906073 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-2517 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201650327%22">01650327 </searchLink><i>NLM ISO Abbreviation: </i>J Affect Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41707717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jad.2026.121423
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 121423
    Titles:
      – TitleFull: Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Weintraub MJ
      – PersonEntity:
          Name:
            NameFull: Jeffrey JK
      – PersonEntity:
          Name:
            NameFull: Ichinose MC
      – PersonEntity:
          Name:
            NameFull: Bergman RL
      – PersonEntity:
          Name:
            NameFull: Shapiro B
      – PersonEntity:
          Name:
            NameFull: Barnett G
      – PersonEntity:
          Name:
            NameFull: Artin H
      – PersonEntity:
          Name:
            NameFull: Lynn M
      – PersonEntity:
          Name:
            NameFull: Salimian A
      – PersonEntity:
          Name:
            NameFull: Grody S
      – PersonEntity:
          Name:
            NameFull: Ramesh R
      – PersonEntity:
          Name:
            NameFull: Eales L
      – PersonEntity:
          Name:
            NameFull: Grob CS
      – PersonEntity:
          Name:
            NameFull: Miklowitz DJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 06
              Text: 2026 Jun 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1573-2517
          Numbering:
            – Type: volume
              Value: 403
          Titles:
            – TitleFull: Journal of affective disorders
              Type: main
ResultId 1